• Galapagos announces that Gilead received a complete response letter for filgotinib for the treatment of moderately to severely active rheumatoid arthritis

    Wednesday August 19th 2020

  • Mithra announces commercial launch of Myring™ in the Netherlands

    Wednesday August 19th 2020

  • BioLizard awarded €300,000 VLAIO research grant to establish causal link between the microbiome and disease

    Monday August 17th 2020

  • Becoming a nerve cell: timing is of the essence

    Monday August 17th 2020

  • Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease

    Thursday August 13th 2020

  • Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study

    Thursday August 13th 2020

  • BISC Global opens in Switzerland

    Wednesday August 12th 2020

  • Precigen ActoBio announces positive topline results from Phase 1b study of AG019 ActoBiotics

    Tuesday August 11th 2020

  • Your news here?

  • Mithra announces shelf life extension for Myring™ to 36 months

    Tuesday August 4th 2020

  • Antelope Dx receives 2,2M euro grant from VLAIO to expand capabilities for its home testing device

    Tuesday August 4th 2020

  • A regulatory network driving heterogeneity in melanoma cells

    Tuesday August 4th 2020


Strategic Partners